Extracorporeal Membrane Oxygenation for ARDS: National Trends in the United States 2008–2012

References

1. 1.↵
   1. Ashbaugh DG,
   2. Bigelow DB,
   3. Petty TL,
   4. Levine BE

   . Acute respiratory distress in adults. Lancet 1967;2(7511):319–323.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Erickson SE,
   2. Martin GS,
   3. Davis JL,
   4. Matthay MA,
   5. Eisner MD

   for the NIH NHLBI ARDS Network. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37(5):1574–1579.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Phua J,
   2. Badia JR,
   3. Adhikari NKJ,
   4. Friedrich JO,
   5. Fowler RA,
   6. Singh JM,
   7. et al

   . Has mortality from acute respiratory distress syndrome decreased over time? AJRCC 2009;179(3):220–27.

   OpenUrl
4. 4.↵
   1. Bellani G,
   2. Laffey JG,
   3. Pham T,
   4. Fan E,
   5. Brochard L,
   6. Esteban A,
   7. et al

   . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788–800.

   OpenUrlCrossRefPubMed
5. 5.↵
   The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301–1308.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Papazian L,
   2. Forel JM,
   3. Gacouin A,
   4. Penot-Ragon C,
   5. Perrin G,
   6. Loundou A,
   7. et al.

   , ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107–1116.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Guérin C,
   2. Reignier J,
   3. Richard JC,
   4. Beuret P,
   5. Gacouin A,
   6. Boulain T,
   7. et al.

   , PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159–2168.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Guerin C,
   2. Debord S,
   3. Leray V,
   4. Delannoy B,
   5. Bayle F,
   6. Bourdin G,
   7. Richard JC

   . Efficacy and safety of recruitment maneuvers in acute respiratory distress syndrome. Ann Intensive Care 2011;1(1):9.

   OpenUrlPubMed
9. 9.
   1. Dellinger RP,
   2. Zimmerman JL,
   3. Taylor RW,
   4. Straube RC,
   5. Hauser DL,
   6. Criner GJ,
   7. et al

   . Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26(1):15–23.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.
    1. Afshari A,
    2. Brok J,
    3. Møller AM,
    4. Wetterslev J

    . Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev. 2010;(7):CD002787.
11. 11.↵
    1. Ferguson ND,
    2. Cook DJ,
    3. Guyatt GH,
    4. Mehta S,
    5. Hand L,
    6. Austin P,
    7. et al.

    , Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013;368(9):795–805.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Brodie D,
    2. Bacchetta M

    . Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med 2011;365(20):1905–1914.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Peek GJ,
    2. Mugford M,
    3. Tiruvoipati R,
    4. Wilson A,
    5. Allen E,
    6. Thalanany MM,
    7. et al

    . for the CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet 2009;374(9698):1351–63.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Hill JD,
    2. O'Brien TG,
    3. Murray JJ,
    4. Dontigny L,
    5. Bramson ML,
    6. Osborn JJ,
    7. Gerbode F

    . Prolonged extracorporeal oxygenation for acute posttraumatic respiratory failure (shock lung syndrome). Use of Bramson membrane lung. N Engl J Med 1972;286(12):629–634.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Zapol WM,
    2. Snider MT,
    3. Hill JD,
    4. Fallat RJ,
    5. Bartlett RH,
    6. Edmunds LH,
    7. et al

    . Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 1979;242(20):2193–2196.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Morris AH,
    2. Wallace CJ,
    3. Menlove RL,
    4. Clemmer TP,
    5. Orme JF Jr..,
    6. Dean NC,
    7. et al

    . Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994;149(2 Pt 1):295–305.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    https://www.hcup-us.ahrq.gov/nisoverview.jsp. Last Updated 11/17/15. Accessed 12/10/15.
18. 18.↵
    1. TenHoor T,
    2. Mannino DM,
    3. Moss M

    . Risk Factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest 2001;119(4):1179–1184.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Stefan MS,
    2. Shieh MS,
    3. Pekow PS,
    4. Rothberg MB,
    5. Steingrub JS,
    6. Lagu T,
    7. Lindenauer PK

    . Epidemiology and outcomes of acute respiratory failure in the United States, 2001-2009: a national survey. J Hosp Med 2013;8(2):76–82.

    OpenUrlPubMed
20. 20.↵
    www.elso.org. Accessed 12/10/15.
21. 21.↵
    1. Schmidt M,
    2. Bailey M,
    3. Sheldrake J,
    4. Hodgson C,
    5. Auborn C,
    6. Rycus PT,
    7. et al

    . Predicting survival after extracorporeal membrane oxygenation for severe respiratory failure. Am J Resp Crit Car 2014;189(11):1374–82.

    OpenUrl
22. 22.↵
    http://www.atsjournals.org/doi/suppl/10.1164/rccm.201311-2023OC/suppl_file/schmidt_data_supplement.pdf.
23. 23.↵
    1. Noah MA,
    2. Peek GJ,
    3. Finney SJ,
    4. Griffiths MJ,
    5. Harrison DA,
    6. Grieve R,
    7. et al

    . Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza (H1N1). JAMA 2011;306(15):1659–68.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory syndrome. JAMA 2009;302(17):1888–1895.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.
    1. Sharma NS,
    2. Wille KM,
    3. Zhi D,
    4. Thannickal VJ,
    5. Brodie DM,
    6. Hoopes CW,
    7. et al

    . Use of ECMO in the management of severe acute respiratory distress syndrome: a survey of academic medical centers in the United States. ASAIO J 2015;61:556–563.

    OpenUrlPubMed
26. 26.↵
    1. Combes A,
    2. Brodie D,
    3. Bartlett R,
    4. Brochard L,
    5. Brower R,
    6. Conard S,
    7. et al

    . Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014;190:488–496.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Morris AH

    . Exciting new ECMO technology awaits compelling scientific evidence for widespread use in adults with respiratory failure. Intensive Care Med 2012;38(2):186–188.

    OpenUrlPubMed
28. 28.↵
    Extracorporeal membrane oxygenator for severe acute respiratory distress syndrome (EOLIA). https://clinicaltrials.gov/ct2/show/NCT01470703. Accessed 12/10/15. Last updated 11/11/15.